Ironwood Pharmaceuticals (IRWD)
(Delayed Data from NSDQ)
$6.39 USD
-0.13 (-1.99%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $6.39 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value B Growth F Momentum B VGM
Brokerage Reports
0 items in cart
Ironwood Pharmaceuticals, Inc. [IRWD]
Reports for Purchase
Showing records 741 - 760 ( 1019 total )
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 15
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense: Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 8This report contains brief updates on the following: IRWD, PCYC. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 8
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense: Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 1
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Q2:14, IRWD Misses on Top and Bottom Line; Expect DTC Campaign to Grow Sales, but at High Costs, Reiterate NEUTRAL and Raising PT
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense-Recent Drug Launch Weekly Retail Sales Tracker- Week Ended July 25
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
The Week Ahead in Life Sciences - Upcoming Events for the Week of August 4
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 18
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Ironwood Pharmaceuticals, Inc.
Industry: Medical - Drugs
Biotechnology/Biopharmaceuticals/BioDefense - Recent Drug Launch Weekly Retail Sales Tracker - Week Ended July 11
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D